Skip to main content
Please join Noticeboard
You are offline
Good Health and Well-being
May 10, 2021

South Africa asks Serum Institute to take back 1 million vaccine doses, says report

Abishek Good Health and Well-being

South Africa has asked the Serum Institute of India to take back the one million COVID-19vaccine doses the company had sent in early February, The Economic Times reported on Tuesday, a week after the country said it will put on hold use of AstraZeneca’s shot in its vaccination program.Serum Institute of India, which is producing AstraZeneca’s shot, has emerged as a key vaccine supplier. One million doses of the COVID-19 vaccine landed in South Africa last week and another 500,000 were due to arrive in the next few weeks.The company did not immediately respond to a Reuters request for comment.South Africa’s health minister has said the government may sell doses of AstraZeneca’s vaccine, after the country paused its roll-out following a small clinical trial that showed it offered minimal protection against mild to moderate illness from the 501Y.V2 coronavirus variant dominant in the country.AstraZeneca has said its vaccine appeared to offer only limited protection against mild disease caused by the South African variant, based on data from a study by South Africa’s University of the Witwatersr and and Oxford University.

Discussion (0)

No comments yet

This notice is currently unavailable

It may have been set to private or is under review

This notice has expired

This notice has been removed

The content is no longer available

South Africa asks Serum Institute to take back 1 million vaccine doses, says report

Good Health and Well-being

South Africa has asked the Serum Institute of India to take back the one million COVID-19vaccine doses the company had sent in early February, The Economic Times reported on Tuesday, a week after the country said it will put on hold use of AstraZeneca’s shot in its vaccination program.Serum Institute of India, which is producing AstraZeneca’s shot, has emerged as a key vaccine supplier. One million doses of the COVID-19 vaccine landed in South Africa last week and another 500,000 were due to arrive in the next few weeks.The company did not immediately respond to a Reuters request for comment.South Africa’s health minister has said the government may sell doses of AstraZeneca’s vaccine, after the country paused its roll-out following a small clinical trial that showed it offered minimal protection against mild to moderate illness from the 501Y.V2 coronavirus variant dominant in the country.AstraZeneca has said its vaccine appeared to offer only limited protection against mild disease caused by the South African variant, based on data from a study by South Africa’s University of the Witwatersr and and Oxford University.

Recent Searches

Recent Noticeboards

No results found

Try a different search term

Something went wrong

No notices yet

No notices match these filters

Couldn't load notices

You're all caught up 🎉

Message

Create 3 Noticeboards to earn this Silver level Community Champion Badge.

View all badges that you can earn

You're only a minute from joining in

Discover Noticeboards

Report Content

Please tell us why you are reporting this content.